Journal of Cancer Education

, Volume 33, Issue 2, pp 298–308 | Cite as

Design and Success of a 21st Century Cancer Education Program at the University of Louisville

Article
  • 196 Downloads

Abstract

Cancer incidence, morbidity, and mortality in the Commonwealth of Kentucky are among the highest in the nation. The University of Louisville was the recipient of a National Cancer Institute (NCI)-funded cancer education program grant in 1975 under the leadership of Dr. Norbert Burzynski. A new and totally redesigned performance-based University of Louisville Cancer Education Program was funded by NCI in 2011 to recruit and motivate outstanding undergraduate and health professional students to pursue further training and careers in cancer research. Here, we describe the strategy, design, methods, implementation, and accomplishments of our twenty-first century performance-based cancer education program. Our program will meet or exceed all of its 5-year performance goals, including the total number students (n = 156) and under-represented minorities (n = 53) who successfully completed the program under the mentorship of cancer research-intensive faculty members of the James Graham Brown Cancer Center (JGBCC). The mentored research program is complemented with professional development and enhancement activities, including cancer research seminars presented by faculty members actively engaged in research centered on the diagnosis, treatment or prevention of cancer, creation of individual career development plans, exploration of cancer research careers, and acquisition of professionalism skills. Student interests towards cancer research significantly increased after completion of the program compared to baseline (P = 0.02). Based on quantitative and qualitative analysis of various components of the curricula, the trainees favor practical, engaging, and interactive activities aligned within professional career goals and objectives. For instance, the trainees prefer two 30-min small group discussions on “Navigating Careers in Cancer Research” with faculty, professional students, and program alumni. Future updates to the program include new activities that capitalize on the cross-disciplinary background of our mentors and trainees as well as a team-based approach to professional development. Our cancer education program will continue to enhance the professional development of the next generation of cancer scientists and clinicians.

Keywords

Cancer education Cancer research and training Summer research program Distinction in research program 

Notes

Acknowledgement

This program is supported by NCI Grant R25-CA134283 and funding from the University of Louisville.

References

  1. 1.
    Bruendermann E, Martin RC (2015) A cost analysis of a pancreatic cancer screening protocol in high-risk populations. Am J Surg 210:409–416CrossRefGoogle Scholar
  2. 2.
    Bruendermann E, Martin RC (2015) High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening. J Surg Res 194:212–219CrossRefGoogle Scholar
  3. 3.
    Cameron C, Collie CL, Chang S (2012) Introducing students to cancer prevention careers through programmed summer research experiences. J Cancer Educ 27:233–242CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Carter JV, Roberts HL, Pan J, Rice JD, Burton JF, Galbraith NJ, Eichenberger MR, Jorden J, Deveaux P, Farmer R, Williford A, Kanaan Z, Rai SN, Galandiuk S (2016) A highly predictive model for diagnosis of colorectal neoplasms using plasma microRNA: Improving specificity and sensitivity. Ann Surg. doi: 10.1097/SLA.0000000000001873
  5. 5.
    Daniel CL, Brooks CM, Waterbor JW (2011) Approaches for longitudinally tracking graduates of NCI-funded short-term cancer research training programs. J Cancer Educ 26:58–63CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Egger ME, McNally LR, Nitz J, McMasters KM, Gomez-Gutierrez JG (2014) Adenovirus-mediated FKHRL1/TM sensitizes melanoma cells to apoptosis induced by temozolomide. Hum Gene Ther Clin Dev 25:186–95CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Gomez-Gutierrez JG, Nitz J, Sharma R, Wechman SL, Riedinger E, Martinez-Jaramillo E, Zhou H, McMasters KM (2016) Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo. Virology 487:249–259CrossRefPubMedGoogle Scholar
  8. 8.
    Gronemeyer SA (2011) Creating synergy: essential components of a successful R25E cancer education program. J Cancer Educ 26:215–222CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Gurka MK, Pender D, Chuong P, Fouts BL, Sobelov A, McNally MW, Mezera M, Woo SY, McNally LR (2016) Identification of pancreatic tumors in vivo with ligand-targeted pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography. J Control Release 231:60–67CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Li X, Li Y, States VA, Li S, Zhang X, Martin RC (2014) The effect of black raspberry extracts on MnSOD activity in protection against concanavalin A induced liver injury. Nutr Cancer 66:930–937CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Lopatto D (2007) Undergraduate research experiences support science career decisions and active learning. CBE Life Sci Educ 6:297–306CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Mitchell JM, Fan TW, Lane AN, Moseley HN (2014) Development and in silico evaluation of large-scale metabolite identification methods using functional group detection for metabolomics. Front Genet 5:237PubMedPubMedCentralGoogle Scholar
  13. 13.
    Nelson B, Carter JV, Eichenberger MR, Netz U, Galandiuk S (2016) Genetic polymorphisms in 5-FU related enzymes predict pathologic response following neoadjuvant chemoradiation for rectal cancer. Surgery. doi: 10.1016/j.surg.2016.05.017
  14. 14.
    Reyes-Reyes EM, Salipur FR, Sharris M, Forsthoefel MK, Bates PJ (2015) Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation. Mol Oncol 9:1392–1405CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Saurabh K, Scherzer MT, Song A, Yip KW, Reed JC, Li C, Beverly LJ (2014) Dissecting the in vivo leukemogenic potency of Bclxl. J Leukemia 2:158Google Scholar
  16. 16.
    Shah PP, Lockwood WW, Saurabh K, Kurlawala Z, Shannon SP, Waigel S, Zacharias W, Beverly LJ (2015) Ubiquilin1 represses migration and epithelial-to-mesenchymal transition of human non-small cell lung cancer cells. Oncogene 34:1709–1717CrossRefPubMedGoogle Scholar
  17. 17.
    Wehry J, Cannon R, Scoggins CR, Puffer L, McMasters KM, Martin RC (2015) Restrictive blood transfusion protocol in liver resection patients reduces blood transfusions with no increase in patient morbidity. Am J Surg 209:280–288CrossRefPubMedGoogle Scholar
  18. 18.
    Xiao D, Barry S, Kmetz D, Egger M, Pan J, Rai SN, Qu J, McMasters KM, Hao H (2016) Melanoma cell-derived exosomes promote epithelial-mesenchymal transition in primary melanocytes through paracrine/autocrine signaling in the tumor microenvironment. Cancer Lett 376:318–327CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Zeiderman MR, Egger ME, Kimbrough CW, England CG, Dupre TV, McMasters KM, McNally LR (2014) Targeting of BRAF resistant melanoma via extracellular matrix metalloproteinase inducer receptor. J Surg Res 190:111–118CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© American Association for Cancer Education 2016

Authors and Affiliations

  1. 1.Department of Pharmacology & Toxicology and James Graham Brown Cancer CenterUniversity of Louisville, Kosair Charities Clinical and Translational ResearchLouisvilleUSA

Personalised recommendations